Rocket


News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

GH Research PLC Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"P.0411 0.015 0.020 0.010 0.005 0.000"
09/29/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression"
08/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Unaudited Condensed Consolidated Interim Financial Statements for the three and six months ended June 30, 2023",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations",
"Condensed Consolidated Interim Statement of Comprehensive Income Three months ended June 30, Six months ended June 30, 2023 $’000 2022 $’000 2023 $’000 2022 $’000",
"Corporate Presentation for August 2023"
07/19/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Notice of Annual General Meeting",
"Directors’ Report and 2022 Irish Statutory Financial Statements",
"Annual General Meeting Notice Regarding Agenda",
"Annual General Meeting Notice Regarding the Availability of Proxy Materials",
"Annual General Meeting Proxy Card (Record Holders)",
"Annual General Meeting Proxy Card (Brokers)"
06/02/2023 20-F/A Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
05/25/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Unaudited Condensed Consolidated Interim Financial Statements for the three months ended March 31, 2023",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations",
"Condensed Consolidated Interim Statement of Comprehensive Income Three months ended March 31, 2023 2022 $’000 $’000",
"Corporate Presentation for May 2023"
03/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
03/20/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
03/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
03/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/09/2023 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
03/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
03/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"(15,100",
"Corporate Presentation for March 2023"
02/14/2023 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 9.4% stake in GH Research PLC
02/14/2023 SC 13G/A Venrock Healthcare Capital Partners II, L.P. reports a 6.8% stake in GH Research PLC
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A FMR LLC reports a 8.6% stake in GH RESEARCH PLC
01/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"GH Research Provides Business Updates and Highlights Key Upcoming Milestones",
"Corporate Presentation for January 2023"
10/14/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Poster for a Phase 1/2 clinical trial of GH001 (GH001-TRD-102), for October 2022",
"Presentation for a Phase 1/2 clinical trial of GH001 (GH001-TRD-102), for October 2022",
"Poster for a Phase 1 clinical trial of GH001 (GH001-HV-101), for October 2022",
"Presentation for a Phase 1 clinical trial of GH001 (GH001-HV-101), for October 2022"
09/22/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
09/21/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Presentation for September 2022",
"Poster for September 2022"
09/16/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
09/08/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
08/23/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Unaudited Condensed Consolidated Interim Financial Statements for the three and six months ended June 30, 2022",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations",
"Dublin, Ireland, August 23, 2022"
08/11/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Notice of Annual General Meeting",
"Directors’ Report and 2021 Irish Statutory Financial Statements",
"Annual General Meeting Notice Regarding Agenda",
"Annual General Meeting Notice Regarding the Availability of Proxy Materials",
"Annual General Meeting Proxy Card (Record Holders)",
"Annual General Meeting Proxy Card (Brokers)"
06/24/2022 6-K Quarterly results
05/31/2022 6-K Quarterly results
05/27/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/18/2022 6-K Quarterly results
05/18/2022 6-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy